Generic Drug Maker Defers Antitrust Prosecution, Pays $7.32M In Settlements
PHILADELPHIA — Generic drug maker Heritage Pharmaceuticals Inc. entered into a deferred prosecution agreement on a criminal charge of price fixing and agreed to pay a total of $7.32 million for...To view the full article, register now.
Already a subscriber? Click here to view full article